About: COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management
Creator	Fischer, Robert Alviggi, Carlo Ubaldi, Filippo Vaiarelli, Alberto Andersen, Claus Banker, Manish Bento, Fabiola Blockeel, Christophe Bühler, Klaus Carbone, Luigi Conforti, Alessandro Dahan, Michael Drakopoulos, Panagiotis Esteves, Sandro Foong, Shu Galliano, Daniela Grynberg, Michael Horton, Marcos Humaidan, Peter Llacer, Joaquin Marca, Antonio Neuspiller, Fernando Orvieto, Raoul Papanikolaou, Evangelos Polyzos, Nikolaos Roque, Matheus Strina, Ida Sunkara, Sesh Tournaye, Herman Vuong, Lan Xavier, Pedro Yarali, Hakan
Source	Medline; PMC
abstract	The prolonged lockdown of health services providing high-complexity fertility treatments –as currently recommended by many reproductive medicine entities– is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born –but who will not be so due to the lockdown of infertility services– might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.
has issue date	2020-05-13(xsd:dateTime)
bibo:doi	10.1186/s12958-020-00605-z
bibo:pmid	32404170
has license	cc-by
sha1sum (hex)	4efb52a369012856b987162de929acfdd83d0062
schema:url	https://doi.org/10.1186/s12958-020-00605-z
resource representing a document's title	COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management
has PubMed Central identifier	PMC7218705
has PubMed identifier	32404170
schema:publication	Reprod Biol Endocrinol
resource representing a document's body	covid:4efb52a369012856b987162de929acfdd83d0062#body_text
is schema:about of	named entity 'health care providers' named entity 'vulnerable' named entity 'order' named entity 'COVID-19' named entity 'conceived' named entity 'contrast' named entity 'assisted reproductive technology' named entity 'OCCUR' named entity 'COMPETENT' named entity 'time' named entity 'number' named entity 'environment' named entity 'care' named entity 'infants' named entity 'represent' named entity 'services' named entity 'fertility treatments' named entity 'infertility' named entity 'Oocyte' named entity 'reproductive medicine' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'assisted reproductive technology' named entity 'assisted reproductive technology' named entity 'clinical management' named entity 'Oocyte' named entity 'identify' named entity 'ART' named entity 'diabetes' named entity 'fertility preservation' named entity 'Telehealth' named entity 'reproductive outcomes' named entity 'pregnancy' named entity 'ART' named entity 'euploidy' named entity 'inflammatory processes' named entity 'embryo' named entity 'GnRH agonist' named entity 'oocyte' named entity 'infertility' named entity 'April 23' named entity 'aneuploidy' named entity 'embryo' named entity 'sperm' named entity 'oocytes' named entity 'euploidy' named entity 'systemic autoimmune diseases' named entity 'gamete' named entity 'live birth' named entity 'open-access'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software